About the Authors
- Megan D. Montgomery
-
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
- Trevor Chan
-
Current address: Stanford University, Stanford, CA, United States of America
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
- Philip M. Swigart
-
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
- Bat-erdene Myagmar
-
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
- Rajesh Dash
-
Current address: Stanford University, Stanford, CA, United States of America
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
- Paul C. Simpson
-
* E-mail: paul.simpson@ucsf.edu
Affiliations Department of Medicine, Cardiology Division, VA Medical Center, San Francisco, CA, United States of America, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States of America
Competing Interests
UCSF owns a patent with PCS as inventor for use of A61603 in heart failure, and PCS is involved in a company to pursue this. The indicated patent owned by UCSF is "Method of treatment using alpha-1-adrenergic agonist compounds" (inventor Paul C. Simpson) (allowed #8324178, 2009). This patent has not resulted in any company, product, employment, etc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: MDM TC RD PCS. Formal analysis: MDM TC PS RD PCS. Funding acquisition: PCS. Investigation: MDM TC PS BM RD. Methodology: MDM TC PS BM RD PCS. Project administration: PCS. Resources: PCS. Supervision: PCS. Validation: MDM TC PS RD PCS. Visualization: MDM PCS. Writing – original draft: MDM PCS. Writing – review & editing: MDM TC PS PCS.